Based on the CAMP4 THERAPEUTICS CORPORATION stock forecast from 0 analysts, the average analyst target price for CAMP4 THERAPEUTICS CORPORATION is not available over the next 12 months. CAMP4 THERAPEUTICS CORPORATION’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CAMP4 THERAPEUTICS CORPORATION is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, CAMP4 THERAPEUTICS CORPORATION’s stock price was USD 11.00. CAMP4 THERAPEUTICS CORPORATION’s stock price has changed by +0.73% over the past week, 0% over the past month and +4,317.67% over the last year.
No recent analyst target price found for CAMP4 THERAPEUTICS CORPORATION
No recent average analyst rating found for CAMP4 THERAPEUTICS CORPORATION
Company Overview CAMP4 THERAPEUTICS CORPORATION
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for CAMP4 THERAPEUTICS CORPORATION (CAMP)
Loading...
Unadjusted Closing Price for CAMP4 THERAPEUTICS CORPORATION (CAMP)
Loading...
Share Trading Volume for CAMP4 THERAPEUTICS CORPORATION Shares
Loading...
Compare Performance of CAMP4 THERAPEUTICS CORPORATION Shares
Frequently Asked Questions About CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock
Stock Target Advisor's fundamental analysis for CAMP4 THERAPEUTICS CORPORATION's stock is Very Bearish.
Unfortunately we do not have enough data on CAMP's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CAMP's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on CAMP's stock to indicate if its overvalued.
The last closing price of CAMP's stock was USD 11.00.
Unfortunately we do not currently have any market capitalization data for CAMP's stock.
Unfortunately we do not have enough analyst data on CAMP's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CAMP4 THERAPEUTICS CORPORATION's stock.
Sorry, we do not have any data on the number of employees for CAMP4 THERAPEUTICS CORPORATION.
Sorry we do not have any infomation available on CAMP4 THERAPEUTICS CORPORATION's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock
Stock Target Advisor's fundamental analysis for CAMP4 THERAPEUTICS CORPORATION's stock is Very Bearish.
Unfortunately we do not have enough data on CAMP's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CAMP's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on CAMP's stock to indicate if its overvalued.
The last closing price of CAMP's stock was USD 11.00.
Unfortunately we do not currently have any market capitalization data for CAMP's stock.
Unfortunately we do not have enough analyst data on CAMP's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CAMP4 THERAPEUTICS CORPORATION's stock.
Sorry, we do not have any data on the number of employees for CAMP4 THERAPEUTICS CORPORATION.
Sorry we do not have any infomation available on CAMP4 THERAPEUTICS CORPORATION's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CAMP !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
